Replies to post #101234 on Biotech Values

[DewDiligence]

VRUS—Looks like the trial has only been pushed back.

In biotech, this kind of purported delay without cause is often employed as a means of saving face. I’ll make you a gentleman’s bet that the phase-2b trial in gentotyoe-2/3 patients never starts.